AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2138684
Drug: Diclofenac (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (25 mg)
Trial: 22466021
Drug: Cognitive-behavioural treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural treatment plus usual neck exercises (PTcb group)
Trial: 17141491
Drug: Mao-to (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mao-to (0.06 g/kg body wt./dose three times daily)
Trial: 17141491
Drug: Oseltamivir (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir (2 mg/kg body wt./dose twice daily)
Trial: 10069678
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II infusion with free NO availability
Trial: 10069678
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II infusion with NO clamp (using L-NMMA)
Trial: 10069678
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II infusion with vitamin C co-infusion
Trial: 10069678
Drug: Saline control
RxNorm normalized name: GLYCERIN 0.53 g in 1 mL CUTANEOUS INJECTION [Glycerol-Saline Control]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline control during angiotensin II infusion
Trial: 7628024
Drug: Lansoprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (30 mg, approximately 1.4 mg.kg‐1 mean) administered at 9:00 pm the night before surgery and at 5:30 am on the morning of surgery
Trial: 31784433
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Traditional Chinese Medicine (TCM) and Western medicine (Xin Jia Xuan Bai Cheng Qi Decoction)
Trial: 31784433
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy alone (Western standard Medicine)
Trial: 28967272
Drug: Initial triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial triple disease-modifying anti-rheumatic drug therapy
Trial: 26796681
Drug: Galantamine (AD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (AD G)
Trial: 26796681
Drug: Placebo (AD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (AD P+G)
Trial: 21626051
Drug: Capecitabine 750
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 750 mg/m² BID for 14 days of a 21-day cycle
Trial: 21626051
Drug: Capecitabine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine 1,000 mg/m² BID for 14 days of a 21-day cycle
Trial: 21626051
Drug: Capecitabine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine 1,000 mg BID flat dose with continuous dosing of sorafenib 400 mg BID
Trial: 19602610
Drug: Twice-daily icodextrin
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily icodextrin administration
Trial: 19602610
Drug: Once-daily icodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily icodextrin administration
Trial: 11790216
Drug: Oral antidiabetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antidiabetic agents (various classes)
Trial: 11790216
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oral antidiabetic agents
Trial: 11790216
Drug: Sulfonylureas and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylureas and metformin
Trial: 7935701
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (0.5 to 0.6 mg per kilogram of body weight per day)
Trial: 7935701
Drug: Fluconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (400 mg per day)
Trial: 894086
Drug: Formalin‐inactivated Mycoplasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formalin‐inactivated Mycoplasma pneumoniae vaccine
Trial: 24491296
Drug: Unilateral ovarian
RxNorm normalized name: modified Vaccinia Ankara-Bavarian Nordic Injection [Jynneos]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral ovarian suspension for 36-48 hours
Trial: 16306060
Drug: Half the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half the recommended dose of vitamin A
Trial: 16306060
Drug: Full recommended
RxNorm normalized name: Full Marks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full recommended dose of vitamin A
Trial: 11907388
Drug: Paracetamol (P
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (P group, n = 8)
Trial: 11907388
Drug: Paracetamol and
RxNorm normalized name: Paracetamol and tramadol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol and tramadol (PT group, n = 29)
Trial: 11907388
Drug: Paracetamol and
RxNorm normalized name: Paracetamol and tramadol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol and nalbuphine (PN group, n = 27)
Trial: 7654268
Drug: Trimethoprim-sulfamethoxazole, 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole, 160 mg/800 mg twice daily
Trial: 7654268
Drug: Nitrofurantoin, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin, 100 mg four times daily
Trial: 6605713
Drug: Cefadroxil, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefadroxil, 500 mg twice daily
Trial: 7654268
Drug: Amoxicillin, 500
RxNorm normalized name: Amoxicillin, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin, 500 mg three times daily
Trial: 1969252
Drug: Dexmedetomidine (optimal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (optimal dose range)
Trial: 31664444
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of 2500 mg of l-citrulline and 250 mg of metformin 3 times a day for 26 weeks
Trial: 24592670
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy-based text messaging intervention
Trial: 22320028
Drug: Intraoperative ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative ketamine administered as a bolus dose of 0.5 mg/kg in 10 mL of normal saline and a continuous intravenous infusion of 4.0 microg/kg/min
Trial: 22320028
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (equal volume to ketamine)
Trial: 19772450
Drug: Simplified titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simplified titration algorithm (6 U per meal starting dose, adjusted in 2-U increments)
Trial: 19772450
Drug: Intensive titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive titration algorithm (doses based on fasting blood glucose, gender, height, and weight, adjusted based on previous 3 days' mean SMBG)
Trial: 19772450
Drug: Intensive titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive titration
Trial: 19772450
Drug: Simplified titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simplified titration
Trial: 17313424
Drug: 1-month reducing
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-month reducing course of oral prednisolone (9 men)
Trial: 15198881
Drug: Broncho‐Vaxom (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broncho‐Vaxom (7 mg, oral capsules, one capsule daily for the first 10 days of each month for 3 months)
Trial: 15198881
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral capsules, one capsule daily for the first 10 days of each month for 3 months)
Trial: 9877488
Drug: Budesonide 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 1.0 mg by inhalation from a pMDI with a Nebuhaler (with charcoal)
Trial: 9877488
Drug: Budesonide 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 1.0 mg by inhalation from a pMDI with a Nebuhaler (without charcoal)
Trial: 9877488
Drug: Budesonide 0.5
RxNorm normalized name: budesonide 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 0.5 mg given intravenously
Trial: 9877488
Drug: Erroneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erroneous administration (canister shaken only before the first actuation)
Trial: 7891985
Drug: 0.5% apraclonidine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% apraclonidine, topically twice daily for 1 week
Trial: 17531897
Drug: Uterotonic medications
RxNorm normalized name: UTEROTONICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uterotonic medications
Trial: 16301850
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (PAC group): PPI (bid), amoxicillin (1,000 mg, bid), clarithromycin (500 mg, bid)
Trial: 16301850
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy (PBMT group): PPI (bid), bismuth subcitrate (300 mg, qid), metronidazole (500 mg, tid), tetracycline (500 mg, qid)
Trial: 11932285
Drug: Glucose ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose ingestion (50 g)
Trial: 11932285
Drug: Glucose ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose ingestion (50 g) during mental stress
Trial: 9654311
Drug: i.v./oral therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v./oral therapy with ciprofloxacin plus metronidazole
Trial: 9654311
Drug: i.v. therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. therapy with ciprofloxacin plus metronidazole
Trial: 7628206
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate 25 mg plus oestradiol cypionate 5 mg (Cyclofem)
Trial: 7628206
Drug: Norethisterone enanthate
RxNorm normalized name: norethindrone enanthate
DrugBank: Norethindrone enanthate (DB14678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethisterone enanthate 50 mg plus oestradiol valerate 5 mg (Mesigyna)
Trial: 2692825
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of ketanserin sublingually
Trial: 2692825
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of ketanserin intravenously
Trial: 2692825
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of nifedipine sublingually
Trial: 401691
Drug: Molsydomine 2
RxNorm normalized name: molsidomine
DrugBank: Molsidomine (DB09282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsydomine 2 mg
Trial: 19025527
Drug: 50 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/kg i.v. magnesium sulphate in 100 ml of 0.9% normal saline
Trial: 19025527
Drug: 50 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/kg i.v. magnesium sulphate
Trial: 17157115
Drug: Paracetamol/tramadol (PIT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol/tramadol (PIT) 325 mg/37.5 mg
Trial: 17157115
Drug: Tramadol (T)
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol (T) 50 mg
Trial: 12684211
Drug: Duodenal fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duodenal fat infusion (triglyceride emulsion, 2.8 kcal/min)
Trial: 12684211
Drug: Duodenal fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duodenal fat infusion with lipase inhibition (120 mg tetrahydrolipstatin)
Trial: 11014323
Drug: Telmisartan 1-160
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan 1-160 mg oral single dose
Trial: 11014323
Drug: Telmisartan 10-160
RxNorm normalized name: telmisartan 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 10-160 mg intravenous single dose
Trial: 11014323
Drug: Telmisartan 320
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan 320 mg oral once daily for 7 days
Trial: 11014323
Drug: Telmisartan 20
RxNorm normalized name: telmisartan 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 20 and 120 mg oral once daily for 7 days
Trial: 11014323
Drug: Telmisartan 10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 10, 20, 40, 80, 120, and 160 mg oral once daily for 7 days
Trial: 11014323
Drug: Telmisartan 40,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40, 80, or 120 mg oral once daily for 28 days
Trial: 3590805
Drug: High-dose prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose prednisolone (2 g of prednisolone-hemisuccinate every 6 hours for 48 hours)
Trial: 18689718
Drug: Nisin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisin (6 microg/mL) applied to the nipple and mammary areola for 2 weeks
Trial: 18689718
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (similar preparation devoid of nisin)
Trial: 16708816
Drug: Harnal (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Harnal (0.2 mg/d)
Trial: 16708816
Drug: Proscar (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proscar (5 mg/d)
Trial: 12778355
Drug: Intensive chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive chemotherapy according to AML-BFM 93 protocol
Trial: 2252527
Drug: prednisone (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prednisone (15 mg/day)
Trial: 393464
Drug: indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin (100 mg/day)
Trial: 28504569
Drug: Blended essential
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blended essential oil (1:1:1 ratio of L. angustifolia, Salvia sclarea, and Origanum majorana)
Trial: 25801289
Drug: THC administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC administration
Trial: 19705105
Drug: Ketotifen (sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen (sedating antihistamine)
Trial: 19705105
Drug: Epinastine (nonsedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinastine (nonsedating antihistamine)
Trial: 11712038
Drug: Topical aspirin/dichloromethane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical aspirin/dichloromethane solution
Trial: 25955224
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone (20 μg/kg/d)
Trial: 25955224
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (200 μg/d)
Trial: 25955224
Drug: Combined estrogens
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined estrogens and oral contraceptive pills (30 μg of ethinyl estradiol plus 150 μg of desogestrel) and 4 mg/d of estradiol valerate
Trial: 23104720
Drug: Adjuvant trastuzumab-based
RxNorm normalized name: Rna-based adjuvant cv8102
DrugBank: CV-8102 (DB19184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant trastuzumab-based chemotherapy (ATBC)
Trial: 23104720
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (ATBC-)
Trial: 10205316
Drug: Folate supplementation
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate supplementation (5 mg/day)
Trial: 1425625
Drug: ondansetron 1
RxNorm normalized name: ondansetron 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 1 mg
Trial: 6372428
Drug: Supplement group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplement group (high-protein beverage)
Trial: 6372428
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine vitamin and mineral tablets)
Trial: 20102879
Drug: Full-dose tenecteplase
RxNorm normalized name: Tenecteplase
DrugBank: Tenecteplase (DB00031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-dose tenecteplase before PCI (f-PCI)
Trial: 16333795
Drug: Continuous anticoagulation
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous anticoagulation therapy (INR 2.0 - 3.0) in patients with AF and LA thrombi
Trial: 12668861
Drug: Glycoprotein IIb/IIIa
RxNorm normalized name: GLYCOPROTEIN IIB/IIIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycoprotein IIb/IIIa inhibitors (specifically abciximab)
Trial: 12668861
Drug: Thienopyridines and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thienopyridines and glycoprotein (GP) IIb/IIIa inhibitors
Trial: 7649753
Drug: Generic discharge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic discharge screens indicating IV fluids or drugs
Trial: 29382477
Drug: 1 day
RxNorm normalized name: ZonaCort 11 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 day preparation with PEG 3350 (4 g/kg/day) + bisacodyl
Trial: 29382477
Drug: 2 days
RxNorm normalized name: Chapstick 12 Days of Christmas KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 days preparation with PEG 3350 (2 g/kg/day) + bisacodyl
Trial: 23090524
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg mifepristone and 800 micrograms buccal misoprostol
Trial: 18594529
Drug: VAPEC-B+G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAPEC-B+G-CSF
Trial: 12043955
Drug: Solution-based intranasal
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution-based intranasal triamcinolone acetonide formulation (Tri-Nasal) at doses of 100, 200, and 400 microg over 7 days
Trial: 12043955
Drug: Aqueous suspension-based
RxNorm normalized name: penicillin G procaine Injectable Suspension [Pen-Aqueous]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous suspension-based triamcinolone acetonide formulation (Nasacort AQ) at doses of 110, 220, and 440 microg
Trial: 10421591
Drug: Oral folic
RxNorm normalized name: folic acid Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral folic acid (5 mg PO) for 4 weeks
Trial: 10421591
Drug: Oral folic
RxNorm normalized name: folic acid Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral folic acid (5 mg PO)
Trial: 27279544
Drug: Everolimus (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus (10 mg once a day)
Trial: 31182181
Drug: Low glycaemic
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low glycaemic index, low insulin index (LGI-LII) meal
Trial: 27832514
Drug: On-demand treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand treatment with BAY 81-8973
Trial: 15043519
Drug: Oral branched
RxNorm normalized name: Machilus thunbergii branch extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral branched chain amino acids
Trial: 11764826
Drug: MD15 Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MD15 Oral Irrigator plus manual brushing
Trial: 9493701
Drug: Barnidipine 20
RxNorm normalized name: barnidipine
DrugBank: Barnidipine (DB09227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barnidipine 20 mg
Trial: 9493701
Drug: Barnidipine 30
RxNorm normalized name: barnidipine
DrugBank: Barnidipine (DB09227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barnidipine 30 mg
Trial: 3324615
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg diclofenac sodium
Trial: 3947505
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg diclofenac sodium
Trial: 30392496
Drug: PsP 750mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PsP 750mg/day in 3 divided doses for 90 days
Trial: 25335686
Drug: Milk enriched
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk enriched with sterols (2.24 g per day)
Trial: 22417253
Drug: Oral laquinimod
RxNorm normalized name: laquinimod
DrugBank: Laquinimod (DB06685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral laquinimod 0.6 mg once daily
Trial: 12604533
Drug: Amoxicillin 25
RxNorm normalized name: amoxicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 25 mg/kg/dose b.i.d.
Trial: 12604533
Drug: Amoxicillin 15
RxNorm normalized name: amoxicillin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 15 mg/kg/dose t.i.d.
Trial: 10390311
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation (ES) of wrist extensors (3 times 30 minutes daily for 8 weeks)
Trial: 16269638
Drug: Standard rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard rehabilitation treatment